 | • レポートコード：MRC2-11QY04969 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はワクチン・予防接種のグローバル市場について調査・分析したレポートです。種類別（サブユニットワクチン、弱毒生ワクチン、複合ワクチン、不活化ワクチン、組換えベクターワクチン、トキソイドワクチン、合成ワクチン、樹状細胞ワクチン）市場規模、用途別（小児科疾患、成人病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ワクチン・予防接種の競争状況、市場シェア ・世界のワクチン・予防接種市場：種類別市場規模 2015年-2020年（サブユニットワクチン、弱毒生ワクチン、複合ワクチン、不活化ワクチン、組換えベクターワクチン、トキソイドワクチン、合成ワクチン、樹状細胞ワクチン） ・世界のワクチン・予防接種市場：種類別市場規模予測 2021年-2026年（サブユニットワクチン、弱毒生ワクチン、複合ワクチン、不活化ワクチン、組換えベクターワクチン、トキソイドワクチン、合成ワクチン、樹状細胞ワクチン） ・世界のワクチン・予防接種市場：用途別市場規模 2015年-2020年（小児科疾患、成人病） ・世界のワクチン・予防接種市場：用途別市場規模予測 2021年-2026年（小児科疾患、成人病） ・北米のワクチン・予防接種市場分析：米国、カナダ ・ヨーロッパのワクチン・予防接種市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのワクチン・予防接種市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のワクチン・予防接種市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのワクチン・予防接種市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、AstraZeneca、Bavarian Nordic、Novartis、Bharat Biotech、Bio-Med、CSL、Emergent BioSolutions、GSK、Johnson & Johnson、Pfizer、Merck、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Vaccination is the administration of antigenic material (avaccine) to stimulate an individual’s immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease.
The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccines; recently developed vaccines that are safer and more effective; better public awareness; technological advancements in molecular genetics domain; and the adoption of novel vaccine delivery mechanisms are primarily driving the growth of the global vaccination market. Moreover, the development of new therapeutic and prophylactic vaccines for combating HIV/AIDS, congenital abnormalities, malaria, SARS and cancer, as well as other fatal diseases is also contributing the market’s growth.
Market Analysis and Insights: Global Vaccines & Vaccination Market
The global Vaccines & Vaccination market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Vaccines & Vaccination Scope and Market Size
Vaccines & Vaccination market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vaccines & Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Market segment by Type, the product can be split into
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Market segment by Application, split into
Pediatrics disease market
Global adults disease
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Vaccines & Vaccination Revenue
1.4 Market by Type
1.4.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Subunit vaccines
1.4.3 Live attenuated vaccines
1.4.4 Conjugate vaccines
1.4.5 Inactivated vaccines
1.4.6 Recombinant vector vaccines
1.4.7 Toxoid vaccines
1.4.8 Synthetic vaccines
1.4.9 Dendritic cell vaccines
1.5 Market by Application
1.5.1 Global Vaccines & Vaccination Market Share by Application: 2020 VS 2026
1.5.2 Pediatrics disease market
1.5.3 Global adults disease
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2015-2026)
2.2 Global Vaccines & Vaccination Growth Trends by Regions
2.2.1 Vaccines & Vaccination Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Vaccines & Vaccination Historic Market Share by Regions (2015-2020)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Vaccines & Vaccination Market Growth Strategy
2.3.6 Primary Interviews with Key Vaccines & Vaccination Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Market Size
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2015-2020)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2015-2020)
3.1.3 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Vaccines & Vaccination Market Concentration Ratio
3.2.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2019
3.3 Vaccines & Vaccination Key Players Head office and Area Served
3.4 Key Players Vaccines & Vaccination Product Solution and Service
3.5 Date of Enter into Vaccines & Vaccination Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2015-2020)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Vaccines & Vaccination Market Size by Application (2015-2020)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2015-2020)
6.2 Vaccines & Vaccination Key Players in North America (2019-2020)
6.3 North America Vaccines & Vaccination Market Size by Type (2015-2020)
6.4 North America Vaccines & Vaccination Market Size by Application (2015-2020)
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2015-2020)
7.2 Vaccines & Vaccination Key Players in Europe (2019-2020)
7.3 Europe Vaccines & Vaccination Market Size by Type (2015-2020)
7.4 Europe Vaccines & Vaccination Market Size by Application (2015-2020)
8 China
8.1 China Vaccines & Vaccination Market Size (2015-2020)
8.2 Vaccines & Vaccination Key Players in China (2019-2020)
8.3 China Vaccines & Vaccination Market Size by Type (2015-2020)
8.4 China Vaccines & Vaccination Market Size by Application (2015-2020)
9 Japan
9.1 Japan Vaccines & Vaccination Market Size (2015-2020)
9.2 Vaccines & Vaccination Key Players in Japan (2019-2020)
9.3 Japan Vaccines & Vaccination Market Size by Type (2015-2020)
9.4 Japan Vaccines & Vaccination Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Vaccines & Vaccination Market Size (2015-2020)
10.2 Vaccines & Vaccination Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Vaccines & Vaccination Market Size by Type (2015-2020)
10.4 Southeast Asia Vaccines & Vaccination Market Size by Application (2015-2020)
11 India
11.1 India Vaccines & Vaccination Market Size (2015-2020)
11.2 Vaccines & Vaccination Key Players in India (2019-2020)
11.3 India Vaccines & Vaccination Market Size by Type (2015-2020)
11.4 India Vaccines & Vaccination Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Vaccines & Vaccination Market Size (2015-2020)
12.2 Vaccines & Vaccination Key Players in Central & South America (2019-2020)
12.3 Central & South America Vaccines & Vaccination Market Size by Type (2015-2020)
12.4 Central & South America Vaccines & Vaccination Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Vaccines & Vaccination Introduction
13.1.4 Abbott Revenue in Vaccines & Vaccination Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Vaccines & Vaccination Introduction
13.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Bavarian Nordic
13.3.1 Bavarian Nordic Company Details
13.3.2 Bavarian Nordic Business Overview
13.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
13.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2015-2020)
13.3.5 Bavarian Nordic Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Vaccines & Vaccination Introduction
13.4.4 Novartis Revenue in Vaccines & Vaccination Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Bharat Biotech
13.5.1 Bharat Biotech Company Details
13.5.2 Bharat Biotech Business Overview
13.5.3 Bharat Biotech Vaccines & Vaccination Introduction
13.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2015-2020)
13.5.5 Bharat Biotech Recent Development
13.6 Bio-Med
13.6.1 Bio-Med Company Details
13.6.2 Bio-Med Business Overview
13.6.3 Bio-Med Vaccines & Vaccination Introduction
13.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2015-2020)
13.6.5 Bio-Med Recent Development
13.7 CSL
13.7.1 CSL Company Details
13.7.2 CSL Business Overview
13.7.3 CSL Vaccines & Vaccination Introduction
13.7.4 CSL Revenue in Vaccines & Vaccination Business (2015-2020)
13.7.5 CSL Recent Development
13.8 Emergent BioSolutions
13.8.1 Emergent BioSolutions Company Details
13.8.2 Emergent BioSolutions Business Overview
13.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
13.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2015-2020)
13.8.5 Emergent BioSolutions Recent Development
13.9 GSK
13.9.1 GSK Company Details
13.9.2 GSK Business Overview
13.9.3 GSK Vaccines & Vaccination Introduction
13.9.4 GSK Revenue in Vaccines & Vaccination Business (2015-2020)
13.9.5 GSK Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview
13.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
13.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Pfizer
10.11.1 Pfizer Company Details
10.11.2 Pfizer Business Overview
10.11.3 Pfizer Vaccines & Vaccination Introduction
10.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2015-2020)
10.11.5 Pfizer Recent Development
13.12 Merck
10.12.1 Merck Company Details
10.12.2 Merck Business Overview
10.12.3 Merck Vaccines & Vaccination Introduction
10.12.4 Merck Revenue in Vaccines & Vaccination Business (2015-2020)
10.12.5 Merck Recent Development
13.13 Sanofi
10.13.1 Sanofi Company Details
10.13.2 Sanofi Business Overview
10.13.3 Sanofi Vaccines & Vaccination Introduction
10.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2015-2020)
10.13.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Vaccines & Vaccination Key Market Segments
Table 2. Key Players Covered: Ranking by Vaccines & Vaccination Revenue
Table 3. Ranking of Global Top Vaccines & Vaccination Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Subunit vaccines
Table 6. Key Players of Live attenuated vaccines
Table 7. Key Players of Conjugate vaccines
Table 8. Key Players of Inactivated vaccines
Table 9. Key Players of Recombinant vector vaccines
Table 10. Key Players of Toxoid vaccines
Table 11. Key Players of Synthetic vaccines
Table 12. Key Players of Dendritic cell vaccines
Table 13. Global Vaccines & Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Vaccines & Vaccination Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Vaccines & Vaccination Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Vaccines & Vaccination Market Share by Regions (2015-2020)
Table 17. Global Vaccines & Vaccination Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Vaccines & Vaccination Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Vaccines & Vaccination Market Growth Strategy
Table 23. Main Points Interviewed from Key Vaccines & Vaccination Players
Table 24. Global Vaccines & Vaccination Revenue by Players (2015-2020) (Million US$)
Table 25. Global Vaccines & Vaccination Market Share by Players (2015-2020)
Table 26. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines & Vaccination as of 2019)
Table 27. Global Vaccines & Vaccination by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Vaccines & Vaccination Product Solution and Service
Table 30. Date of Enter into Vaccines & Vaccination Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 33. Global Vaccines & Vaccination Market Size Share by Type (2015-2020)
Table 34. Global Vaccines & Vaccination Revenue Market Share by Type (2021-2026)
Table 35. Global Vaccines & Vaccination Market Size Share by Application (2015-2020)
Table 36. Global Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 37. Global Vaccines & Vaccination Market Size Share by Application (2021-2026)
Table 38. North America Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 40. North America Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 41. North America Vaccines & Vaccination Market Share by Type (2015-2020)
Table 42. North America Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 43. North America Vaccines & Vaccination Market Share by Application (2015-2020)
Table 44. Europe Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 46. Europe Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Vaccines & Vaccination Market Share by Type (2015-2020)
Table 48. Europe Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Vaccines & Vaccination Market Share by Application (2015-2020)
Table 50. China Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 51. China Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 52. China Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 53. China Vaccines & Vaccination Market Share by Type (2015-2020)
Table 54. China Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 55. China Vaccines & Vaccination Market Share by Application (2015-2020)
Table 56. Japan Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 58. Japan Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Vaccines & Vaccination Market Share by Type (2015-2020)
Table 60. Japan Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Vaccines & Vaccination Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 64. Southeast Asia Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Vaccines & Vaccination Market Share by Type (2015-2020)
Table 66. Southeast Asia Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Vaccines & Vaccination Market Share by Application (2015-2020)
Table 68. India Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 69. India Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 70. India Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 71. India Vaccines & Vaccination Market Share by Type (2015-2020)
Table 72. India Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 73. India Vaccines & Vaccination Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Vaccines & Vaccination Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Vaccines & Vaccination Market Share (2019-2020)
Table 76. Central & South America Vaccines & Vaccination Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Vaccines & Vaccination Market Share by Type (2015-2020)
Table 78. Central & South America Vaccines & Vaccination Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Vaccines & Vaccination Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. AstraZeneca Company Details
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Product
Table 88. AstraZeneca Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 89. AstraZeneca Recent Development
Table 90. Bavarian Nordic Company Details
Table 91. Bavarian Nordic Business Overview
Table 92. Bavarian Nordic Product
Table 93. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 94. Bavarian Nordic Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Bharat Biotech Company Details
Table 101. Bharat Biotech Business Overview
Table 102. Bharat Biotech Product
Table 103. Bharat Biotech Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 104. Bharat Biotech Recent Development
Table 105. Bio-Med Company Details
Table 106. Bio-Med Business Overview
Table 107. Bio-Med Product
Table 108. Bio-Med Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 109. Bio-Med Recent Development
Table 110. CSL Company Details
Table 111. CSL Business Overview
Table 112. CSL Product
Table 113. CSL Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 114. CSL Recent Development
Table 115. Emergent BioSolutions Business Overview
Table 116. Emergent BioSolutions Product
Table 117. Emergent BioSolutions Company Details
Table 118. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 119. Emergent BioSolutions Recent Development
Table 120. GSK Company Details
Table 121. GSK Business Overview
Table 122. GSK Product
Table 123. GSK Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 124. GSK Recent Development
Table 125. Johnson & Johnson Company Details
Table 126. Johnson & Johnson Business Overview
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 129. Johnson & Johnson Recent Development
Table 130. Pfizer Company Details
Table 131. Pfizer Business Overview
Table 132. Pfizer Product
Table 133. Pfizer Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 134. Pfizer Recent Development
Table 135. Merck Company Details
Table 136. Merck Business Overview
Table 137. Merck Product
Table 138. Merck Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 139. Merck Recent Development
Table 140. Sanofi Company Details
Table 141. Sanofi Business Overview
Table 142. Sanofi Product
Table 143. Sanofi Revenue in Vaccines & Vaccination Business (2015-2020) (Million US$)
Table 144. Sanofi Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccines & Vaccination Market Share by Type: 2020 VS 2026
Figure 2. Subunit vaccines Features
Figure 3. Live attenuated vaccines Features
Figure 4. Conjugate vaccines Features
Figure 5. Inactivated vaccines Features
Figure 6. Recombinant vector vaccines Features
Figure 7. Toxoid vaccines Features
Figure 8. Synthetic vaccines Features
Figure 9. Dendritic cell vaccines Features
Figure 10. Global Vaccines & Vaccination Market Share by Application: 2020 VS 2026
Figure 11. Pediatrics disease market Case Studies
Figure 12. Global adults disease Case Studies
Figure 13. Vaccines & Vaccination Report Years Considered
Figure 14. Global Vaccines & Vaccination Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Vaccines & Vaccination Market Share by Regions: 2020 VS 2026
Figure 16. Global Vaccines & Vaccination Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Vaccines & Vaccination Market Share by Players in 2019
Figure 19. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines & Vaccination as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2019
Figure 21. North America Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Vaccines & Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…- フルミストワクチンの世界市場（～2026年） An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 獣医用ワクチンの世界市場（～2026年） Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock product…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…